Comprehensive evaluation and personalised treatment planning for lung cancer, including surgical and non-surgical treatment options based on the type, stage and individual clinical condition.
Lung cancer develops when abnormal cells in the lung grow uncontrollably. The major categories include non-small cell lung cancer and small cell lung cancer. The treatment approach depends on the cancer type, stage, tumour characteristics and the patient's overall health.
Lung cancer can present differently from one patient to another. Some cancers may be detected during investigations before major symptoms appear, while others may present with persistent cough, breathing difficulty, chest discomfort or other symptoms.
Accurate diagnosis and staging are important before deciding on treatment. Imaging, biopsy, pathology and other investigations may be required to understand the extent and characteristics of the disease.
Depending on the individual case, treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy or combinations of these approaches.
Treatment decisions are based on factors such as cancer type, stage, tumour location, lymph node involvement, molecular findings, lung function and overall health.
Identifying the type of lung cancer is an important part of treatment planning because different types can require different treatment approaches.
NSCLC is the most common broad category of lung cancer and includes types such as adenocarcinoma and squamous cell carcinoma. Treatment depends on stage and other tumour characteristics.
Small cell lung cancer is a distinct type of lung cancer and is generally treated differently from non-small cell lung cancer. Treatment commonly involves systemic therapy and may include radiation depending on the clinical situation.
Adenocarcinoma is a type of non-small cell lung cancer. Treatment planning depends on its stage, location, pathology and relevant molecular or biomarker findings.
Squamous cell carcinoma is another type of non-small cell lung cancer. Its management depends on the extent of disease and the patient's individual clinical condition.
Lung cancer may not always cause noticeable symptoms in its early stages. Persistent or unexplained respiratory symptoms should be medically evaluated.
A cough that persists or changes over time should be evaluated, particularly when accompanied by other symptoms.
Unexplained or persistent difficulty breathing may require medical assessment.
Persistent chest pain or discomfort can have many causes and should be evaluated when it does not resolve.
Coughing up blood requires medical evaluation to determine its underlying cause.
Persistent changes in voice can occur with several conditions and may require further evaluation.
Unexplained weight loss, fatigue or reduced appetite can occur with several illnesses and should be assessed appropriately.
Diagnosis involves determining whether cancer is present, identifying its type and establishing how extensively it has spread.
The exact investigations required depend on the clinical presentation and the information needed to establish the diagnosis and treatment plan.
Staging helps determine the extent of lung cancer and is an important part of deciding which treatment approaches may be appropriate.
Cancer is confined to the lung in many stage I cases. Surgery or other local treatment may be considered depending on the individual case.
Treatment may involve surgery together with additional treatment depending on tumour and lymph node characteristics.
Treatment may involve combinations of systemic therapy, radiation and surgery in selected situations.
When cancer has spread to distant areas, treatment commonly focuses on systemic therapies and other treatments selected according to tumour characteristics and individual needs.
Surgery may be considered when lung cancer can be removed safely and the patient's overall health allows an operation. The extent of surgery depends on tumour location, size, stage and lung function.
Removal of the tumour together with a small amount of surrounding lung tissue. It may be considered in selected situations.
Removal of a specific anatomical segment of a lung lobe while preserving more surrounding lung tissue.
Removal of the affected lobe of the lung. It is an important surgical option for selected resectable lung cancers.
Removal of an entire lung may be required for selected tumours when a more limited resection is not appropriate.
Selected patients may be candidates for minimally invasive approaches such as VATS or robotic surgery. Suitability depends on tumour characteristics, anatomy, stage and the overall clinical situation.
Video-assisted thoracoscopic surgery uses small access points to perform selected thoracic procedures.
Robotic-assisted surgery may be considered for selected lung cancer operations where the approach is clinically appropriate.
Lung cancer treatment may involve surgery, systemic therapy, radiation therapy or combinations of different treatments depending on the cancer type and stage.
Medicines may be used before surgery, after surgery or for advanced disease depending on the treatment plan.
Radiation may be used to treat the primary tumour, nearby disease or selected areas of metastatic cancer.
Patients whose tumours have specific molecular alterations may be considered for targeted medicines when appropriate.
Immunotherapy may be used in appropriate patients, either alone or in combination with other treatments depending on tumour characteristics and treatment setting.
Lung cancer treatment may involve coordination between surgical oncology, medical oncology, radiation oncology, radiology, pathology and other healthcare professionals.
Confirm the cancer type and obtain the necessary pathology and imaging information.
Determine the extent of disease using appropriate imaging and diagnostic investigations.
Review surgery, systemic treatment, radiation and other appropriate options.
Continue clinical monitoring and follow-up according to the individual treatment plan.
Two patients with lung cancer can have very different treatment plans. The appropriate approach depends on the cancer type, stage, tumour location, molecular findings, lung function and overall health.
A detailed review of scans, pathology and staging information helps determine which treatment approaches may be appropriate.
Treatment planning may take into account:
Your treatment journey begins with understanding the diagnosis and continues through treatment planning, treatment and follow-up.
Your medical history, symptoms, previous reports and imaging are reviewed.
Necessary investigations are reviewed to establish the extent and characteristics of the cancer.
Appropriate surgical and non-surgical treatment options are discussed based on the diagnosis.
Treatment is followed by appropriate recovery planning and continued clinical monitoring.
Dr. Nitin Singhal is a surgical oncologist in Ahmedabad with experience in cancer surgery, including thoracic and other solid-tumour procedures.
Lung cancer surgery is planned after detailed evaluation of the tumour, staging information, lung function and overall health.
Lung cancer treatment requires accurate diagnosis, appropriate staging and an individualised treatment plan. Depending on the type and stage of lung cancer, treatment may involve surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy or combinations of these approaches.
For selected patients with resectable lung cancer, surgery may be an important part of treatment. Surgical procedures can include wedge resection, segmentectomy, lobectomy or pneumonectomy depending on the tumour and the patient's clinical condition.
Minimally invasive approaches such as video-assisted thoracoscopic surgery and robotic surgery may be considered for selected patients. The choice of surgical approach depends on tumour location, size, stage, anatomy and other factors identified during evaluation.
Patients seeking lung cancer treatment in Ahmedabad can undergo a detailed consultation to review their diagnosis, scans, pathology reports and available treatment options.
Read experiences shared by patients following their cancer treatment.
“The doctor and the team explained the treatment process clearly and supported us throughout the treatment journey.”
“The consultation was detailed and the treatment options were explained in a clear and understandable way.”
“We received clear guidance about the diagnosis, surgery and follow-up care.”
Common questions about lung cancer diagnosis, surgery and treatment.
Surgery may be considered for selected patients, particularly when the cancer can be removed and the patient's overall health allows an operation. The decision depends on the cancer type, stage, tumour location and other clinical factors.
Lobectomy is an important surgical option for selected lung cancers. Other procedures such as wedge resection, segmentectomy or pneumonectomy may be considered depending on the individual case.
Robotic or minimally invasive surgery may be suitable for selected patients. Suitability depends on tumour characteristics, anatomy, stage and the surgeon's assessment.
No. Treatment depends on the type and stage of lung cancer. Surgery is one treatment option and may be combined with or replaced by other treatments depending on the clinical situation.
Depending on the case, evaluation may include chest imaging, CT or PET-CT, biopsy, bronchoscopy, lymph node assessment, pathology and molecular testing. Additional investigations may be recommended for staging and treatment planning.
Yes. Depending on the type and stage, lung cancer may be treated with radiation therapy, chemotherapy, targeted therapy, immunotherapy or combinations of these treatments.
A consultation may be appropriate after a lung tumour has been identified or lung cancer has been diagnosed, particularly when surgery is being considered. Previous scans, pathology reports and treatment records can help during the consultation.
Discuss your diagnosis, staging reports and available treatment options with a surgical oncology team.
Explore specialised cancer treatment and surgical oncology services, organised by area of expertise.
Advanced surgical approaches for selected complex cancers.
Specialised surgical oncology care for women's cancers.
Specialised treatment and surgical care for ovarian cancer.
Comprehensive care for selected gynaecological cancers.
Individualised cervical cancer evaluation and surgical care.
Surgical and multidisciplinary care for uterine cancers.
Specialised surgical care for gastrointestinal cancers.
Cancer care for the urinary system and male reproductive organs.
Comprehensive surgical care for urological cancers.
Specialised surgical treatment for kidney cancer.
Personalised surgical care for prostate cancer.
Evaluation and surgical treatment of testicular cancer.
Diagnosis and surgical management of bladder cancer.
Specialised surgical oncology care for head and neck cancers.
Specialised surgical care for breast cancer.
Specialised cancer care for children and young patients.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
